Clinical trials: Hammertoe
Flexible Hammertoe, Semi-flexible Hammertoe
Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT)
The primary purpose of this study is to assess the long-term safety of treatment and retreatment with KN3835 for flexible/semi-flexible HMT.
- Trial name
- NCT07846280
- Testing
- KN3835
- Volunteers
- 470 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Flexible Hammertoe, Semi-flexible Hammertoe
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)
The primary purpose of this study is to assess the efficacy, safety, and tolerability of KN3835 compared to placebo in the treatment of flexible/semi-flexible HMT.
- Trial name
- NCT07759362
- Testing
- KN3835
- Where
- 7 sites in United States
- Volunteers
- 554 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Hammertoe, Hammer Toe Syndrome
Mg Alloy DrillPins in Hammertoe Deformity Correction
This is a prospective, single-arm clinical feasibility study evaluating the safe application of a novel lean absorbable magnesium-zinc-calcium alloy (ZX00) drill pin (RemeOs™ DrillPin) for the surgical correction of hammertoe…
- Trial name
- NCT07121790
- Testing
- Implant Mg-based RemeOs™ drillpins
- Volunteers
- 20 people
- Sponsor
- Bioretec Ltd.